Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Antigens, CD | 22 | 2016 | 4026 | 1.290 |
Why?
|
GATA1 Transcription Factor | 3 | 2018 | 293 | 1.160 |
Why?
|
Immunoenzyme Techniques | 48 | 2013 | 1799 | 1.120 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 28 | 2021 | 1378 | 1.110 |
Why?
|
Hodgkin Disease | 29 | 2023 | 1415 | 1.100 |
Why?
|
Bone Marrow | 20 | 2023 | 2948 | 0.990 |
Why?
|
Leukemia, Monocytic, Acute | 2 | 2022 | 58 | 0.930 |
Why?
|
Integrin alpha Chains | 2 | 2014 | 97 | 0.920 |
Why?
|
Myeloproliferative Disorders | 10 | 2023 | 606 | 0.880 |
Why?
|
Immunohistochemistry | 59 | 2021 | 11366 | 0.860 |
Why?
|
Lymphoma, B-Cell | 17 | 2023 | 931 | 0.840 |
Why?
|
Mesothelioma | 12 | 2014 | 818 | 0.830 |
Why?
|
Hematologic Neoplasms | 4 | 2023 | 1832 | 0.830 |
Why?
|
Dendritic Cells | 16 | 2023 | 2725 | 0.800 |
Why?
|
Leukemia, Megakaryoblastic, Acute | 2 | 2017 | 48 | 0.770 |
Why?
|
Leukemia, Hairy Cell | 5 | 2017 | 82 | 0.770 |
Why?
|
Lymphoma, T-Cell, Peripheral | 1 | 2022 | 134 | 0.720 |
Why?
|
Histiocytic Necrotizing Lymphadenitis | 3 | 2021 | 23 | 0.670 |
Why?
|
Lymphoma, T-Cell | 5 | 2014 | 299 | 0.660 |
Why?
|
Leukemoid Reaction | 1 | 2018 | 15 | 0.640 |
Why?
|
Lymphoma, Non-Hodgkin | 19 | 2018 | 1381 | 0.640 |
Why?
|
Megakaryocytes | 3 | 2022 | 545 | 0.620 |
Why?
|
Leukemia, Erythroblastic, Acute | 2 | 2017 | 189 | 0.620 |
Why?
|
Leukemia, Myeloid, Acute | 12 | 2023 | 3524 | 0.600 |
Why?
|
Pleural Effusion, Malignant | 3 | 2014 | 101 | 0.570 |
Why?
|
Receptors, Transferrin | 2 | 2016 | 296 | 0.560 |
Why?
|
Keratins | 21 | 2006 | 515 | 0.560 |
Why?
|
Lymphoma | 28 | 2005 | 1877 | 0.560 |
Why?
|
Molecular Chaperones | 2 | 2016 | 743 | 0.560 |
Why?
|
Histiocytosis, Langerhans-Cell | 5 | 2017 | 171 | 0.550 |
Why?
|
Antibodies, Monoclonal | 26 | 2014 | 9274 | 0.540 |
Why?
|
Enteropathy-Associated T-Cell Lymphoma | 1 | 2014 | 12 | 0.510 |
Why?
|
Plasma Cells | 9 | 2021 | 591 | 0.510 |
Why?
|
Immunophenotyping | 23 | 2019 | 1880 | 0.500 |
Why?
|
Adenocarcinoma | 17 | 2014 | 6364 | 0.490 |
Why?
|
Leukemia, T-Cell | 1 | 2014 | 104 | 0.490 |
Why?
|
Reed-Sternberg Cells | 8 | 2018 | 73 | 0.440 |
Why?
|
Skin Neoplasms | 12 | 2023 | 5692 | 0.430 |
Why?
|
Diagnosis, Differential | 34 | 2022 | 12961 | 0.430 |
Why?
|
Lymphoproliferative Disorders | 8 | 2019 | 524 | 0.430 |
Why?
|
Membrane Glycoproteins | 11 | 2009 | 3771 | 0.420 |
Why?
|
Mediastinal Neoplasms | 8 | 2015 | 423 | 0.400 |
Why?
|
Lymph Nodes | 20 | 2017 | 3476 | 0.400 |
Why?
|
WT1 Proteins | 2 | 2002 | 178 | 0.390 |
Why?
|
T-Lymphocytes | 32 | 2021 | 10183 | 0.390 |
Why?
|
Interferon Regulatory Factors | 2 | 2023 | 270 | 0.380 |
Why?
|
Lymphoma, Mantle-Cell | 5 | 2019 | 233 | 0.380 |
Why?
|
Blood Proteins | 1 | 2016 | 1124 | 0.380 |
Why?
|
Lymphocytes | 14 | 2016 | 2617 | 0.370 |
Why?
|
Nuclear Proteins | 10 | 2023 | 5856 | 0.360 |
Why?
|
Neoplasm Proteins | 10 | 2015 | 3707 | 0.360 |
Why?
|
Down Syndrome | 1 | 2018 | 880 | 0.350 |
Why?
|
B-Lymphocytes | 31 | 2021 | 4666 | 0.350 |
Why?
|
Glycoproteins | 7 | 2006 | 2266 | 0.330 |
Why?
|
Lectins, C-Type | 4 | 2007 | 589 | 0.320 |
Why?
|
Leukemia, Plasma Cell | 2 | 2019 | 48 | 0.320 |
Why?
|
Antigens, Neoplasm | 13 | 2009 | 1988 | 0.310 |
Why?
|
Polyps | 2 | 2004 | 189 | 0.310 |
Why?
|
Humans | 262 | 2023 | 744366 | 0.290 |
Why?
|
Gastrointestinal Neoplasms | 3 | 2014 | 990 | 0.290 |
Why?
|
Receptors, Immunologic | 5 | 2012 | 1423 | 0.290 |
Why?
|
Lymphoma, Follicular | 6 | 2012 | 435 | 0.290 |
Why?
|
Gene Rearrangement | 7 | 2012 | 1179 | 0.280 |
Why?
|
Lymphoma, Large-Cell, Anaplastic | 2 | 2008 | 169 | 0.280 |
Why?
|
Carrier Proteins | 10 | 2010 | 5023 | 0.280 |
Why?
|
Interleukin-3 Receptor alpha Subunit | 2 | 2023 | 39 | 0.270 |
Why?
|
Histiocytes | 10 | 2007 | 103 | 0.260 |
Why?
|
Erythroid Cells | 2 | 2017 | 239 | 0.250 |
Why?
|
Paraffin Embedding | 4 | 2014 | 299 | 0.250 |
Why?
|
Gene Expression Regulation, Neoplastic | 14 | 2021 | 8432 | 0.250 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 7 | 2013 | 1596 | 0.250 |
Why?
|
Heart Neoplasms | 1 | 2007 | 374 | 0.230 |
Why?
|
Antigens, Surface | 10 | 2007 | 1663 | 0.230 |
Why?
|
Microfilament Proteins | 5 | 2010 | 1152 | 0.230 |
Why?
|
Translocation, Genetic | 9 | 2016 | 1420 | 0.230 |
Why?
|
Plasmacytoma | 3 | 2021 | 183 | 0.230 |
Why?
|
Histiocytosis | 2 | 2002 | 40 | 0.230 |
Why?
|
SOXC Transcription Factors | 1 | 2023 | 40 | 0.230 |
Why?
|
Killer Cells, Natural | 3 | 2019 | 2133 | 0.230 |
Why?
|
Endometrial Hyperplasia | 1 | 2004 | 97 | 0.220 |
Why?
|
Neoplasms, Plasma Cell | 2 | 2021 | 36 | 0.220 |
Why?
|
beta 2-Microglobulin | 4 | 2018 | 315 | 0.220 |
Why?
|
Apolipoproteins | 4 | 2002 | 317 | 0.220 |
Why?
|
Biopsy, Needle | 4 | 2014 | 1641 | 0.220 |
Why?
|
Sensitivity and Specificity | 10 | 2018 | 14723 | 0.210 |
Why?
|
Sarcoma, Myeloid | 1 | 2023 | 59 | 0.210 |
Why?
|
Myeloid Differentiation Factor 88 | 2 | 2019 | 571 | 0.210 |
Why?
|
Biopsy | 18 | 2023 | 6755 | 0.210 |
Why?
|
Histocytochemistry | 17 | 1987 | 719 | 0.210 |
Why?
|
Phosphoric Monoester Hydrolases | 1 | 2004 | 431 | 0.200 |
Why?
|
Female | 129 | 2023 | 380193 | 0.200 |
Why?
|
Membrane Transport Proteins | 5 | 2002 | 1031 | 0.200 |
Why?
|
Proteoglycans | 2 | 2005 | 837 | 0.200 |
Why?
|
Protein-Tyrosine Kinases | 5 | 2020 | 2455 | 0.200 |
Why?
|
Langerhans Cells | 2 | 2017 | 173 | 0.200 |
Why?
|
Leukemia, Myeloid | 2 | 2006 | 707 | 0.200 |
Why?
|
Lymphatic Diseases | 3 | 2009 | 323 | 0.190 |
Why?
|
Autoimmune Lymphoproliferative Syndrome | 1 | 2020 | 13 | 0.190 |
Why?
|
Kallikreins | 7 | 1983 | 258 | 0.180 |
Why?
|
Male | 111 | 2023 | 350115 | 0.180 |
Why?
|
Sarcoma | 5 | 2022 | 1897 | 0.180 |
Why?
|
Immunoglobulin kappa-Chains | 3 | 1999 | 173 | 0.180 |
Why?
|
Spleen | 9 | 2012 | 2362 | 0.180 |
Why?
|
Mucin-1 | 7 | 2009 | 543 | 0.180 |
Why?
|
Tryptases | 1 | 2020 | 190 | 0.180 |
Why?
|
Multiple Myeloma | 12 | 2021 | 5181 | 0.170 |
Why?
|
Cyclin D1 | 4 | 2017 | 463 | 0.170 |
Why?
|
Middle Aged | 84 | 2021 | 213390 | 0.170 |
Why?
|
Colic | 1 | 2019 | 42 | 0.170 |
Why?
|
Histological Techniques | 5 | 1991 | 198 | 0.170 |
Why?
|
Frozen Sections | 4 | 2014 | 155 | 0.160 |
Why?
|
Waldenstrom Macroglobulinemia | 5 | 2019 | 1052 | 0.160 |
Why?
|
Myeloid Cells | 3 | 2010 | 810 | 0.160 |
Why?
|
Blast Crisis | 2 | 2010 | 103 | 0.160 |
Why?
|
Mutation | 15 | 2023 | 29786 | 0.160 |
Why?
|
Proto-Oncogene Proteins c-myc | 2 | 2016 | 988 | 0.160 |
Why?
|
Mutation, Missense | 4 | 2020 | 2566 | 0.160 |
Why?
|
Bone Marrow Cells | 7 | 2019 | 2513 | 0.160 |
Why?
|
Chromosomes, Human, Pair 9 | 2 | 2018 | 535 | 0.160 |
Why?
|
Neoplasm, Residual | 2 | 2021 | 973 | 0.160 |
Why?
|
Palatine Tonsil | 7 | 2001 | 193 | 0.160 |
Why?
|
Aged | 66 | 2021 | 163288 | 0.150 |
Why?
|
Peripheral Nerves | 1 | 2021 | 466 | 0.150 |
Why?
|
Neoplasms, Second Primary | 3 | 2019 | 1062 | 0.150 |
Why?
|
Histocompatibility Antigens Class II | 3 | 2018 | 1475 | 0.150 |
Why?
|
Neoplasm Metastasis | 6 | 2010 | 4851 | 0.150 |
Why?
|
Mastocytosis | 1 | 2020 | 160 | 0.150 |
Why?
|
Actins | 3 | 2002 | 2121 | 0.150 |
Why?
|
Receptors, Progesterone | 1 | 2002 | 1098 | 0.150 |
Why?
|
Cell Transformation, Neoplastic | 8 | 2019 | 2943 | 0.150 |
Why?
|
Pleural Neoplasms | 3 | 2009 | 607 | 0.150 |
Why?
|
Anemia, Diamond-Blackfan | 1 | 2018 | 137 | 0.150 |
Why?
|
Histocompatibility Antigens Class I | 2 | 2016 | 1366 | 0.150 |
Why?
|
Proto-Oncogene Proteins c-rel | 3 | 2005 | 71 | 0.140 |
Why?
|
PTEN Phosphohydrolase | 3 | 2010 | 1142 | 0.140 |
Why?
|
Clinical Trials, Phase I as Topic | 1 | 2018 | 323 | 0.140 |
Why?
|
Cation Transport Proteins | 3 | 2005 | 327 | 0.140 |
Why?
|
Adult | 84 | 2023 | 214052 | 0.140 |
Why?
|
GTP-Binding Proteins | 4 | 2009 | 970 | 0.140 |
Why?
|
Antibodies, Neoplasm | 2 | 2009 | 286 | 0.140 |
Why?
|
Gene Expression | 4 | 2019 | 7798 | 0.140 |
Why?
|
Lymphoma, B-Cell, Marginal Zone | 2 | 2013 | 180 | 0.140 |
Why?
|
Transcription Factors | 7 | 2018 | 12207 | 0.140 |
Why?
|
Myositis, Inclusion Body | 3 | 2007 | 147 | 0.140 |
Why?
|
Polymyositis | 2 | 2007 | 75 | 0.140 |
Why?
|
Histiocytosis, Sinus | 1 | 2016 | 47 | 0.140 |
Why?
|
Flow Cytometry | 12 | 2021 | 5974 | 0.140 |
Why?
|
Remission Induction | 5 | 2019 | 2385 | 0.140 |
Why?
|
Carcinoembryonic Antigen | 5 | 1987 | 349 | 0.140 |
Why?
|
Umbilical Cord | 1 | 1997 | 180 | 0.140 |
Why?
|
In Situ Hybridization, Fluorescence | 5 | 2016 | 2649 | 0.140 |
Why?
|
Skin | 7 | 2023 | 4372 | 0.140 |
Why?
|
Testicular Neoplasms | 2 | 2015 | 806 | 0.130 |
Why?
|
Granuloma, Plasma Cell | 3 | 2001 | 84 | 0.130 |
Why?
|
Carcinoma | 8 | 2019 | 2375 | 0.130 |
Why?
|
Proto-Oncogene Proteins c-kit | 1 | 2020 | 776 | 0.130 |
Why?
|
Chromosome Aberrations | 5 | 2016 | 1813 | 0.130 |
Why?
|
Staining and Labeling | 9 | 1994 | 1101 | 0.130 |
Why?
|
Vincristine | 12 | 2008 | 1039 | 0.130 |
Why?
|
Cyclophilin A | 1 | 2015 | 57 | 0.130 |
Why?
|
Fetal Death | 1 | 1997 | 448 | 0.130 |
Why?
|
Herpesvirus 4, Human | 4 | 2001 | 1041 | 0.130 |
Why?
|
Microscopy, Electron | 12 | 2014 | 2646 | 0.130 |
Why?
|
Germinal Center | 1 | 1998 | 377 | 0.130 |
Why?
|
Cyclophosphamide | 12 | 2018 | 2242 | 0.120 |
Why?
|
Amino Acid Substitution | 1 | 2019 | 1793 | 0.120 |
Why?
|
Ribosomes | 1 | 2018 | 500 | 0.120 |
Why?
|
Chromosomes, Human, Pair 6 | 2 | 1992 | 380 | 0.120 |
Why?
|
Cerebellar Neoplasms | 1 | 1999 | 587 | 0.120 |
Why?
|
MAP Kinase Kinase 1 | 1 | 2016 | 335 | 0.120 |
Why?
|
Viral Matrix Proteins | 2 | 1998 | 186 | 0.120 |
Why?
|
T-Lymphocytes, Cytotoxic | 2 | 2009 | 1821 | 0.120 |
Why?
|
Myelodysplastic Syndromes | 3 | 2020 | 1352 | 0.120 |
Why?
|
Herpesvirus 8, Human | 4 | 2001 | 258 | 0.120 |
Why?
|
Muscle, Skeletal | 4 | 2021 | 4925 | 0.120 |
Why?
|
Skin Diseases | 3 | 2020 | 1066 | 0.120 |
Why?
|
Mast Cells | 2 | 2020 | 1544 | 0.120 |
Why?
|
Indoles | 1 | 2002 | 1839 | 0.120 |
Why?
|
Receptors, Estrogen | 1 | 2002 | 2190 | 0.120 |
Why?
|
Antigens, Differentiation, Myelomonocytic | 2 | 1992 | 294 | 0.120 |
Why?
|
Colonic Polyps | 1 | 2019 | 542 | 0.120 |
Why?
|
Lymphocyte Activation | 5 | 2005 | 5524 | 0.120 |
Why?
|
Antigens, Differentiation, B-Lymphocyte | 7 | 2019 | 318 | 0.120 |
Why?
|
Burkitt Lymphoma | 1 | 2016 | 327 | 0.120 |
Why?
|
Lymphoma, Large-Cell, Immunoblastic | 2 | 2011 | 26 | 0.110 |
Why?
|
Vasculitis | 2 | 1997 | 519 | 0.110 |
Why?
|
Tumor Suppressor Proteins | 1 | 2004 | 2850 | 0.110 |
Why?
|
Stromal Cells | 3 | 2006 | 1355 | 0.110 |
Why?
|
Epidermis | 4 | 1985 | 528 | 0.110 |
Why?
|
Prognosis | 19 | 2023 | 29060 | 0.110 |
Why?
|
Peroxidase | 2 | 1997 | 611 | 0.110 |
Why?
|
Paraffin | 5 | 1991 | 35 | 0.110 |
Why?
|
Cell Proliferation | 5 | 2017 | 10483 | 0.110 |
Why?
|
Antigens, Differentiation, T-Lymphocyte | 3 | 2008 | 906 | 0.110 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 2 | 2009 | 1038 | 0.110 |
Why?
|
Receptors, IgE | 1 | 1994 | 389 | 0.100 |
Why?
|
Karyotyping | 5 | 2007 | 1243 | 0.100 |
Why?
|
Malaria, Cerebral | 1 | 2013 | 135 | 0.100 |
Why?
|
Glomerulonephritis | 1 | 2014 | 372 | 0.100 |
Why?
|
Antigens | 6 | 2002 | 1466 | 0.100 |
Why?
|
Dendritic Cells, Follicular | 2 | 2009 | 53 | 0.100 |
Why?
|
Neoplasms | 10 | 2022 | 21696 | 0.100 |
Why?
|
Fetal Proteins | 1 | 2012 | 94 | 0.100 |
Why?
|
Cell Differentiation | 11 | 2017 | 11486 | 0.100 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 1997 | 689 | 0.100 |
Why?
|
MicroRNAs | 2 | 2021 | 3751 | 0.100 |
Why?
|
Histiocytoma, Benign Fibrous | 1 | 1992 | 109 | 0.100 |
Why?
|
Neuroblastoma | 3 | 2009 | 1226 | 0.100 |
Why?
|
Chromosomes, Human, Pair 4 | 1 | 1992 | 374 | 0.100 |
Why?
|
Janus Kinase 2 | 2 | 2017 | 528 | 0.100 |
Why?
|
Immunoglobulin J-Chains | 1 | 1991 | 27 | 0.100 |
Why?
|
Kidney Glomerulus | 1 | 2014 | 697 | 0.100 |
Why?
|
Sarcoidosis | 2 | 2016 | 506 | 0.100 |
Why?
|
Carcinoma, Hepatocellular | 2 | 2002 | 2214 | 0.100 |
Why?
|
Lectins | 3 | 1988 | 513 | 0.100 |
Why?
|
Adolescent | 29 | 2021 | 85779 | 0.100 |
Why?
|
Gastrointestinal Diseases | 2 | 2019 | 1170 | 0.100 |
Why?
|
Mice, SCID | 5 | 2020 | 2716 | 0.100 |
Why?
|
Receptors, Complement 3d | 3 | 2009 | 118 | 0.100 |
Why?
|
Receptors, Complement 3b | 3 | 2009 | 145 | 0.100 |
Why?
|
Cell Nucleus | 4 | 2017 | 2969 | 0.100 |
Why?
|
Blotting, Western | 2 | 2018 | 5181 | 0.100 |
Why?
|
Mice, Inbred NOD | 4 | 2020 | 1879 | 0.090 |
Why?
|
S100 Proteins | 2 | 2007 | 259 | 0.090 |
Why?
|
Biopsy, Fine-Needle | 1 | 2016 | 1094 | 0.090 |
Why?
|
Polymerase Chain Reaction | 7 | 2014 | 6171 | 0.090 |
Why?
|
Tumor Microenvironment | 2 | 2020 | 3590 | 0.090 |
Why?
|
Aged, 80 and over | 21 | 2021 | 57776 | 0.090 |
Why?
|
Genetic Markers | 1 | 2017 | 2634 | 0.090 |
Why?
|
Body Fluids | 2 | 2002 | 319 | 0.090 |
Why?
|
Antibody Specificity | 3 | 1990 | 1095 | 0.090 |
Why?
|
Immunochemistry | 8 | 1986 | 124 | 0.090 |
Why?
|
Receptors, Antigen, B-Cell | 7 | 2004 | 548 | 0.090 |
Why?
|
Receptor, Notch1 | 1 | 2013 | 502 | 0.090 |
Why?
|
Chromosomes, Human, Pair 1 | 1 | 1992 | 658 | 0.090 |
Why?
|
Seminoma | 2 | 2009 | 139 | 0.090 |
Why?
|
Soft Tissue Neoplasms | 5 | 2007 | 1363 | 0.090 |
Why?
|
Synovial Membrane | 4 | 1995 | 507 | 0.090 |
Why?
|
Doxorubicin | 10 | 2008 | 2234 | 0.090 |
Why?
|
Rabbits | 3 | 2013 | 4894 | 0.090 |
Why?
|
Cytodiagnosis | 1 | 2014 | 435 | 0.090 |
Why?
|
Antigens, Viral | 1 | 1994 | 1035 | 0.090 |
Why?
|
Prednisone | 6 | 2008 | 1574 | 0.090 |
Why?
|
Erythroid Precursor Cells | 1 | 2010 | 218 | 0.090 |
Why?
|
Protein Precursors | 5 | 1985 | 1154 | 0.090 |
Why?
|
Receptors, Chemokine | 2 | 2003 | 670 | 0.090 |
Why?
|
Hospitals | 1 | 2023 | 3954 | 0.090 |
Why?
|
Cryoultramicrotomy | 1 | 2009 | 17 | 0.090 |
Why?
|
Predictive Value of Tests | 4 | 2018 | 15078 | 0.090 |
Why?
|
Leukemia | 5 | 1985 | 1510 | 0.090 |
Why?
|
Granuloma Annulare | 1 | 2009 | 28 | 0.090 |
Why?
|
Pleural Effusion | 2 | 1996 | 337 | 0.090 |
Why?
|
Lung Neoplasms | 8 | 2008 | 13104 | 0.090 |
Why?
|
Ascitic Fluid | 2 | 2002 | 192 | 0.090 |
Why?
|
Child | 19 | 2022 | 77709 | 0.080 |
Why?
|
Fluorescent Antibody Technique, Direct | 1 | 2009 | 69 | 0.080 |
Why?
|
Headache | 1 | 2017 | 1226 | 0.080 |
Why?
|
X-Linked Inhibitor of Apoptosis Protein | 1 | 2009 | 63 | 0.080 |
Why?
|
Retrospective Studies | 19 | 2023 | 77460 | 0.080 |
Why?
|
Antigens, Differentiation | 1 | 2012 | 927 | 0.080 |
Why?
|
Silicone Elastomers | 1 | 1988 | 84 | 0.080 |
Why?
|
Epitopes | 3 | 1994 | 2571 | 0.080 |
Why?
|
Ovarian Neoplasms | 3 | 2002 | 4839 | 0.080 |
Why?
|
Glucose Transporter Type 1 | 1 | 2009 | 193 | 0.080 |
Why?
|
Interleukin-1beta | 1 | 2014 | 972 | 0.080 |
Why?
|
DNA Nucleotidylexotransferase | 1 | 1988 | 64 | 0.080 |
Why?
|
Carboxylic Ester Hydrolases | 2 | 1997 | 98 | 0.080 |
Why?
|
Receptors, Interleukin-2 | 1 | 1990 | 573 | 0.080 |
Why?
|
Graft vs Host Disease | 2 | 2020 | 2958 | 0.080 |
Why?
|
Clinical Enzyme Tests | 1 | 1988 | 115 | 0.080 |
Why?
|
Breast Neoplasms | 10 | 2019 | 20824 | 0.080 |
Why?
|
Transcription Factor AP-1 | 1 | 2010 | 317 | 0.080 |
Why?
|
Clusterin | 2 | 2009 | 72 | 0.080 |
Why?
|
Sperm Tail | 1 | 2007 | 18 | 0.080 |
Why?
|
TNF Receptor-Associated Factor 1 | 2 | 2005 | 50 | 0.080 |
Why?
|
Hyperplasia | 4 | 2001 | 1185 | 0.080 |
Why?
|
Autopsy | 2 | 2022 | 1020 | 0.080 |
Why?
|
Liver Neoplasms | 3 | 2002 | 4253 | 0.080 |
Why?
|
Kartagener Syndrome | 1 | 2007 | 32 | 0.080 |
Why?
|
Syndecans | 2 | 2005 | 79 | 0.080 |
Why?
|
Rosette Formation | 4 | 1981 | 153 | 0.080 |
Why?
|
Crohn Disease | 2 | 2019 | 2304 | 0.080 |
Why?
|
DNA Nucleotidyltransferases | 1 | 1988 | 193 | 0.080 |
Why?
|
Dendritic Cell Sarcoma, Follicular | 1 | 2007 | 30 | 0.080 |
Why?
|
Pancreas | 3 | 1983 | 1687 | 0.080 |
Why?
|
Ribosomal Proteins | 2 | 2018 | 360 | 0.080 |
Why?
|
Hematologic Diseases | 1 | 1991 | 498 | 0.080 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 4 | 2010 | 1520 | 0.080 |
Why?
|
Myosins | 2 | 1986 | 409 | 0.080 |
Why?
|
Integrases | 1 | 2010 | 533 | 0.070 |
Why?
|
Pericardial Effusion | 2 | 2002 | 247 | 0.070 |
Why?
|
Central Nervous System Neoplasms | 1 | 2015 | 895 | 0.070 |
Why?
|
Liver Diseases | 2 | 2010 | 1253 | 0.070 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 3 | 2012 | 1434 | 0.070 |
Why?
|
Interferon-gamma | 2 | 2020 | 3207 | 0.070 |
Why?
|
Mannose-Binding Lectins | 1 | 2007 | 100 | 0.070 |
Why?
|
Histocompatibility Antigens | 2 | 1985 | 471 | 0.070 |
Why?
|
Interferon-beta | 2 | 2007 | 324 | 0.070 |
Why?
|
Oligonucleotide Array Sequence Analysis | 4 | 2005 | 3921 | 0.070 |
Why?
|
Syndecan-1 | 2 | 2005 | 165 | 0.070 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2020 | 3326 | 0.070 |
Why?
|
Joint Prosthesis | 1 | 1988 | 258 | 0.070 |
Why?
|
Child, Preschool | 13 | 2021 | 41005 | 0.070 |
Why?
|
Histiocytic Disorders, Malignant | 1 | 2006 | 16 | 0.070 |
Why?
|
Lymphohistiocytosis, Hemophagocytic | 1 | 2010 | 260 | 0.070 |
Why?
|
Phenotype | 11 | 2009 | 16367 | 0.070 |
Why?
|
B-Lymphocyte Subsets | 3 | 2009 | 246 | 0.070 |
Why?
|
Tumor Suppressor Protein p14ARF | 1 | 2006 | 90 | 0.070 |
Why?
|
Estrogens | 3 | 1986 | 1566 | 0.070 |
Why?
|
Amyloidosis | 3 | 2000 | 796 | 0.070 |
Why?
|
Immunologic Surveillance | 1 | 2006 | 93 | 0.070 |
Why?
|
Infant | 11 | 2020 | 35134 | 0.070 |
Why?
|
Immunosuppressive Agents | 1 | 2019 | 4153 | 0.070 |
Why?
|
Genetic Loci | 1 | 2015 | 2575 | 0.070 |
Why?
|
Genotype | 5 | 2019 | 12952 | 0.070 |
Why?
|
Animals | 27 | 2021 | 168768 | 0.070 |
Why?
|
Macrophages | 7 | 2013 | 5660 | 0.070 |
Why?
|
Membrane Proteins | 4 | 2005 | 7882 | 0.070 |
Why?
|
Genes, T-Cell Receptor | 1 | 2005 | 29 | 0.070 |
Why?
|
Apolipoproteins D | 4 | 2002 | 14 | 0.070 |
Why?
|
Mice | 17 | 2021 | 81201 | 0.060 |
Why?
|
Interleukin-6 | 2 | 2014 | 3203 | 0.060 |
Why?
|
Clone Cells | 5 | 2021 | 1692 | 0.060 |
Why?
|
Muscle, Smooth | 2 | 1986 | 934 | 0.060 |
Why?
|
Chromosomes, Human, Pair 11 | 3 | 2006 | 417 | 0.060 |
Why?
|
Cost-Benefit Analysis | 2 | 2017 | 5388 | 0.060 |
Why?
|
Gene Expression Profiling | 7 | 2011 | 9445 | 0.060 |
Why?
|
Antigen Presentation | 3 | 2018 | 1284 | 0.060 |
Why?
|
Multiple Sclerosis | 1 | 2019 | 3079 | 0.060 |
Why?
|
Trypsin | 1 | 1985 | 511 | 0.060 |
Why?
|
Receptor Protein-Tyrosine Kinases | 4 | 2008 | 1660 | 0.060 |
Why?
|
Interferon-alpha | 2 | 2007 | 895 | 0.060 |
Why?
|
Seizures | 1 | 2017 | 2859 | 0.060 |
Why?
|
Intestinal Polyps | 2 | 2004 | 100 | 0.060 |
Why?
|
Iron | 2 | 2005 | 1774 | 0.060 |
Why?
|
Epithelium | 5 | 1987 | 1679 | 0.060 |
Why?
|
Lymphoid Tissue | 4 | 1997 | 455 | 0.060 |
Why?
|
Infectious Mononucleosis | 2 | 1998 | 131 | 0.060 |
Why?
|
Hemochromatosis | 1 | 2005 | 184 | 0.060 |
Why?
|
Islets of Langerhans | 4 | 1983 | 1352 | 0.060 |
Why?
|
Paraproteinemias | 2 | 2012 | 246 | 0.060 |
Why?
|
Androgens | 2 | 1986 | 1281 | 0.060 |
Why?
|
Cilia | 1 | 2007 | 466 | 0.060 |
Why?
|
Cholesteatoma | 1 | 1983 | 26 | 0.060 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 13 | 2008 | 11525 | 0.060 |
Why?
|
Neoplasms, Germ Cell and Embryonal | 1 | 2009 | 501 | 0.060 |
Why?
|
Brain Neoplasms | 2 | 2019 | 8861 | 0.060 |
Why?
|
Exons | 1 | 2009 | 2439 | 0.060 |
Why?
|
Iron Overload | 1 | 2005 | 242 | 0.060 |
Why?
|
Endometrial Neoplasms | 1 | 1992 | 1351 | 0.060 |
Why?
|
Endometrium | 1 | 2006 | 424 | 0.060 |
Why?
|
Kidney Transplantation | 3 | 2014 | 4251 | 0.050 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2006 | 705 | 0.050 |
Why?
|
Pericardium | 1 | 2007 | 667 | 0.050 |
Why?
|
Vaginal Smears | 1 | 2006 | 511 | 0.050 |
Why?
|
Ear Neoplasms | 1 | 1983 | 117 | 0.050 |
Why?
|
Hemoglobins | 3 | 2010 | 1532 | 0.050 |
Why?
|
Dermatomyositis | 1 | 2005 | 224 | 0.050 |
Why?
|
Disease Models, Animal | 3 | 2019 | 18034 | 0.050 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2020 | 5445 | 0.050 |
Why?
|
Crystallization | 2 | 2002 | 525 | 0.050 |
Why?
|
Genes, Wilms Tumor | 1 | 2002 | 94 | 0.050 |
Why?
|
Fibromatosis, Abdominal | 1 | 2001 | 24 | 0.050 |
Why?
|
Cell Count | 2 | 2004 | 1856 | 0.050 |
Why?
|
Formaldehyde | 3 | 1990 | 353 | 0.050 |
Why?
|
Cell Line, Tumor | 6 | 2019 | 16690 | 0.050 |
Why?
|
Fluorescent Antibody Technique, Indirect | 1 | 2002 | 429 | 0.050 |
Why?
|
Reproducibility of Results | 3 | 2016 | 19905 | 0.050 |
Why?
|
Endothelium, Vascular | 1 | 2014 | 4459 | 0.050 |
Why?
|
Neoplastic Cells, Circulating | 1 | 1988 | 934 | 0.050 |
Why?
|
Microtubule-Associated Proteins | 1 | 2006 | 1085 | 0.050 |
Why?
|
Chromosomes, Human, Pair 18 | 2 | 1999 | 245 | 0.050 |
Why?
|
Heart Atria | 1 | 2007 | 1356 | 0.050 |
Why?
|
Myoglobin | 1 | 1981 | 160 | 0.050 |
Why?
|
Splenic Diseases | 1 | 2001 | 94 | 0.050 |
Why?
|
Lung | 3 | 2022 | 9857 | 0.050 |
Why?
|
Adrenal Cortex Neoplasms | 1 | 2002 | 162 | 0.050 |
Why?
|
Graft Rejection | 1 | 2014 | 4397 | 0.050 |
Why?
|
Immunoglobulin Heavy Chains | 4 | 2009 | 659 | 0.050 |
Why?
|
Endoplasmic Reticulum | 1 | 2007 | 1146 | 0.050 |
Why?
|
Ear, Middle | 1 | 1983 | 334 | 0.050 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 3 | 2009 | 693 | 0.050 |
Why?
|
Sarcoma, Kaposi | 1 | 2004 | 370 | 0.050 |
Why?
|
Chromosomes, Human, Pair 13 | 1 | 2021 | 197 | 0.050 |
Why?
|
T-Lymphocytes, Regulatory | 2 | 1993 | 2988 | 0.050 |
Why?
|
Paget Disease, Extramammary | 3 | 1985 | 45 | 0.050 |
Why?
|
Inclusion Bodies | 1 | 2002 | 279 | 0.050 |
Why?
|
Lymphoma, T-Cell, Cutaneous | 1 | 2002 | 207 | 0.050 |
Why?
|
Complementarity Determining Regions | 1 | 2021 | 149 | 0.050 |
Why?
|
Tropomyosin | 1 | 2000 | 102 | 0.050 |
Why?
|
Naphthol AS D Esterase | 1 | 1979 | 14 | 0.050 |
Why?
|
Herpesviridae Infections | 2 | 2001 | 277 | 0.050 |
Why?
|
Base Sequence | 5 | 2019 | 12797 | 0.050 |
Why?
|
Apocrine Glands | 3 | 1985 | 31 | 0.040 |
Why?
|
Sweat Glands | 3 | 1985 | 31 | 0.040 |
Why?
|
Cell Movement | 4 | 2015 | 5218 | 0.040 |
Why?
|
Neoplasm Staging | 9 | 2016 | 11031 | 0.040 |
Why?
|
Immunoglobulins | 3 | 2005 | 881 | 0.040 |
Why?
|
Hamartoma | 2 | 1992 | 238 | 0.040 |
Why?
|
Cell Lineage | 4 | 2016 | 2504 | 0.040 |
Why?
|
Peanut Agglutinin | 3 | 1988 | 19 | 0.040 |
Why?
|
Cytokines | 2 | 2011 | 7323 | 0.040 |
Why?
|
Proto-Oncogene Proteins | 3 | 2001 | 4554 | 0.040 |
Why?
|
Hepatocytes | 2 | 2005 | 1211 | 0.040 |
Why?
|
Molecular Biology | 1 | 2023 | 596 | 0.040 |
Why?
|
Integrin beta3 | 1 | 1999 | 122 | 0.040 |
Why?
|
Pseudolymphoma | 1 | 1999 | 30 | 0.040 |
Why?
|
Digestive System | 2 | 2019 | 253 | 0.040 |
Why?
|
Antigen-Presenting Cells | 2 | 2020 | 973 | 0.040 |
Why?
|
Fixatives | 2 | 1991 | 94 | 0.040 |
Why?
|
fms-Like Tyrosine Kinase 3 | 1 | 2022 | 491 | 0.040 |
Why?
|
Platelet Membrane Glycoproteins | 1 | 1999 | 293 | 0.040 |
Why?
|
Aminosalicylic Acids | 2 | 1976 | 37 | 0.040 |
Why?
|
Cell Division | 5 | 1997 | 4569 | 0.040 |
Why?
|
Mycosis Fungoides | 3 | 1991 | 163 | 0.040 |
Why?
|
Databases, Factual | 1 | 2014 | 7730 | 0.040 |
Why?
|
Recurrence | 3 | 2019 | 8340 | 0.040 |
Why?
|
Lung Diseases | 2 | 2007 | 1887 | 0.040 |
Why?
|
Joint Diseases | 1 | 1983 | 479 | 0.040 |
Why?
|
Pineal Gland | 1 | 1999 | 166 | 0.040 |
Why?
|
Consanguinity | 1 | 2020 | 454 | 0.040 |
Why?
|
Alleles | 2 | 2019 | 6933 | 0.040 |
Why?
|
Rhabdomyosarcoma | 1 | 1981 | 382 | 0.040 |
Why?
|
Chromosome Disorders | 1 | 2021 | 514 | 0.040 |
Why?
|
Gene Frequency | 2 | 2019 | 3587 | 0.040 |
Why?
|
Breast Implants | 1 | 2002 | 387 | 0.040 |
Why?
|
Disease Progression | 4 | 2019 | 13286 | 0.040 |
Why?
|
Neoplasm Transplantation | 2 | 2014 | 2086 | 0.040 |
Why?
|
DNA-Binding Proteins | 4 | 2007 | 9647 | 0.040 |
Why?
|
Fluorescent Antibody Technique | 3 | 2020 | 2505 | 0.040 |
Why?
|
Thymus Neoplasms | 1 | 2000 | 268 | 0.040 |
Why?
|
Multigene Family | 1 | 2021 | 1102 | 0.040 |
Why?
|
Peptide Hydrolases | 1 | 1981 | 634 | 0.040 |
Why?
|
Bone Marrow Examination | 1 | 2017 | 157 | 0.040 |
Why?
|
Prostate | 1 | 1986 | 1775 | 0.040 |
Why?
|
Muramidase | 1 | 1977 | 174 | 0.040 |
Why?
|
Tissue Distribution | 4 | 2007 | 2327 | 0.040 |
Why?
|
Kidney | 4 | 2002 | 7184 | 0.040 |
Why?
|
Philadelphia Chromosome | 1 | 2017 | 112 | 0.040 |
Why?
|
Adenofibroma | 2 | 1983 | 25 | 0.040 |
Why?
|
Carcinoma, Squamous Cell | 6 | 2001 | 4034 | 0.040 |
Why?
|
Carcinoma, Neuroendocrine | 1 | 2001 | 332 | 0.040 |
Why?
|
Brain | 4 | 2019 | 26388 | 0.040 |
Why?
|
Homeostasis | 2 | 2006 | 3339 | 0.040 |
Why?
|
Clonal Anergy | 1 | 1997 | 169 | 0.040 |
Why?
|
RNA Interference | 2 | 2018 | 2890 | 0.040 |
Why?
|
Reference Values | 2 | 1997 | 4982 | 0.040 |
Why?
|
Cells, Cultured | 7 | 2018 | 19233 | 0.040 |
Why?
|
Immunoglobulin Fc Fragments | 1 | 1979 | 279 | 0.040 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 4 | 2008 | 4751 | 0.040 |
Why?
|
Calreticulin | 1 | 2017 | 98 | 0.040 |
Why?
|
Acquired Immunodeficiency Syndrome | 2 | 2004 | 2232 | 0.040 |
Why?
|
5' Untranslated Regions | 1 | 2018 | 249 | 0.040 |
Why?
|
Isoniazid | 2 | 1976 | 274 | 0.040 |
Why?
|
Cohort Studies | 5 | 2023 | 40559 | 0.040 |
Why?
|
Granulocytes | 3 | 1996 | 548 | 0.040 |
Why?
|
Receptors, Mitogen | 2 | 1986 | 62 | 0.030 |
Why?
|
Receptors, Thrombopoietin | 1 | 2017 | 157 | 0.030 |
Why?
|
Cytoplasm | 4 | 1982 | 1536 | 0.030 |
Why?
|
Subrenal Capsule Assay | 1 | 2016 | 26 | 0.030 |
Why?
|
Tibia | 1 | 1982 | 1077 | 0.030 |
Why?
|
NF-kappa B | 1 | 2005 | 2499 | 0.030 |
Why?
|
Chromosome Deletion | 1 | 2021 | 1401 | 0.030 |
Why?
|
Algorithms | 1 | 2017 | 13882 | 0.030 |
Why?
|
Enzyme Activation | 3 | 2008 | 3702 | 0.030 |
Why?
|
Renal Dialysis | 2 | 1998 | 1783 | 0.030 |
Why?
|
Immunoglobulin M | 4 | 2012 | 1537 | 0.030 |
Why?
|
Molecular Sequence Data | 6 | 2009 | 18111 | 0.030 |
Why?
|
Mice, Transgenic | 3 | 2019 | 9735 | 0.030 |
Why?
|
von Willebrand Factor | 1 | 1999 | 669 | 0.030 |
Why?
|
Encephalitis | 1 | 1999 | 425 | 0.030 |
Why?
|
Granuloma | 3 | 1988 | 319 | 0.030 |
Why?
|
17-Ketosteroids | 2 | 1974 | 39 | 0.030 |
Why?
|
Mastitis | 1 | 1975 | 41 | 0.030 |
Why?
|
Nematoda | 1 | 1975 | 30 | 0.030 |
Why?
|
Erythrocytes | 4 | 2000 | 2455 | 0.030 |
Why?
|
Sequence Analysis, DNA | 3 | 2016 | 4805 | 0.030 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2019 | 3595 | 0.030 |
Why?
|
Cell Separation | 3 | 2010 | 1751 | 0.030 |
Why?
|
Intestinal Diseases, Parasitic | 1 | 1975 | 66 | 0.030 |
Why?
|
Immune Sera | 4 | 1983 | 641 | 0.030 |
Why?
|
Survival Rate | 5 | 2012 | 12788 | 0.030 |
Why?
|
Heart Ventricles | 1 | 2007 | 3817 | 0.030 |
Why?
|
Mesoderm | 3 | 1992 | 686 | 0.030 |
Why?
|
Proteins | 2 | 2007 | 6100 | 0.030 |
Why?
|
Survival Analysis | 5 | 2019 | 10252 | 0.030 |
Why?
|
Fusion Proteins, bcr-abl | 1 | 1997 | 434 | 0.030 |
Why?
|
Cell Cycle | 1 | 2003 | 2967 | 0.030 |
Why?
|
Apoptosis | 3 | 2014 | 9724 | 0.030 |
Why?
|
Interleukin-17 | 1 | 2020 | 901 | 0.030 |
Why?
|
Pregnancy Trimester, Second | 1 | 1997 | 732 | 0.030 |
Why?
|
Duodenal Ulcer | 1 | 1994 | 125 | 0.030 |
Why?
|
AIDS-Related Opportunistic Infections | 1 | 1997 | 657 | 0.030 |
Why?
|
CD4-CD8 Ratio | 1 | 1993 | 112 | 0.030 |
Why?
|
Dysgerminoma | 2 | 2009 | 66 | 0.030 |
Why?
|
Review Literature as Topic | 1 | 2016 | 336 | 0.030 |
Why?
|
Genes, Neoplasm | 1 | 2016 | 376 | 0.030 |
Why?
|
Mastectomy, Segmental | 1 | 2019 | 956 | 0.030 |
Why?
|
Young Adult | 4 | 2017 | 56429 | 0.030 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2019 | 1771 | 0.030 |
Why?
|
Turner Syndrome | 1 | 1974 | 130 | 0.030 |
Why?
|
Monocytes | 4 | 2014 | 2596 | 0.030 |
Why?
|
Epstein-Barr Virus Nuclear Antigens | 1 | 1994 | 150 | 0.030 |
Why?
|
Methods | 5 | 1982 | 1129 | 0.030 |
Why?
|
Neprilysin | 2 | 2006 | 439 | 0.030 |
Why?
|
Cell Membrane | 4 | 2007 | 3749 | 0.030 |
Why?
|
Mice, Mutant Strains | 2 | 2007 | 1865 | 0.030 |
Why?
|
Cell Line | 4 | 2001 | 16000 | 0.030 |
Why?
|
Gene Deletion | 1 | 2021 | 2751 | 0.030 |
Why?
|
In Situ Hybridization | 3 | 2004 | 1950 | 0.030 |
Why?
|
Isoantigens | 1 | 1995 | 567 | 0.030 |
Why?
|
Chromosome Banding | 1 | 1992 | 278 | 0.030 |
Why?
|
Carcinoma, Transitional Cell | 3 | 1985 | 808 | 0.030 |
Why?
|
Immunologic Techniques | 4 | 1989 | 219 | 0.030 |
Why?
|
Bone Neoplasms | 2 | 1982 | 2530 | 0.030 |
Why?
|
Gastrointestinal Tract | 1 | 2019 | 814 | 0.030 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2018 | 1157 | 0.030 |
Why?
|
Sjogren's Syndrome | 2 | 1975 | 234 | 0.030 |
Why?
|
Pedigree | 1 | 2020 | 4642 | 0.030 |
Why?
|
Genetic Heterogeneity | 1 | 2016 | 733 | 0.030 |
Why?
|
Fatal Outcome | 1 | 1997 | 1851 | 0.030 |
Why?
|
Duffy Blood-Group System | 1 | 2012 | 58 | 0.030 |
Why?
|
alpha 1-Antichymotrypsin | 1 | 1991 | 20 | 0.030 |
Why?
|
Follow-Up Studies | 10 | 2014 | 39052 | 0.030 |
Why?
|
3' Untranslated Regions | 1 | 2014 | 513 | 0.030 |
Why?
|
Chemokines, CC | 2 | 2003 | 291 | 0.030 |
Why?
|
Bleomycin | 6 | 1990 | 512 | 0.030 |
Why?
|
Fibroblast Growth Factor 2 | 1 | 1994 | 599 | 0.030 |
Why?
|
Treatment Outcome | 6 | 2018 | 63107 | 0.030 |
Why?
|
Tissue Array Analysis | 1 | 2013 | 553 | 0.030 |
Why?
|
Tuberculosis, Pulmonary | 2 | 1976 | 810 | 0.030 |
Why?
|
Hypersensitivity | 1 | 2020 | 1102 | 0.030 |
Why?
|
Toxoplasmosis | 2 | 1985 | 91 | 0.020 |
Why?
|
Tritium | 4 | 1974 | 745 | 0.020 |
Why?
|
Down-Regulation | 2 | 2014 | 3001 | 0.020 |
Why?
|
Neoplastic Stem Cells | 2 | 2014 | 1376 | 0.020 |
Why?
|
T-Lymphocyte Subsets | 2 | 2010 | 1837 | 0.020 |
Why?
|
Enterocytes | 2 | 2005 | 225 | 0.020 |
Why?
|
Lymphadenitis | 2 | 1985 | 98 | 0.020 |
Why?
|
Signal Transduction | 4 | 2019 | 23404 | 0.020 |
Why?
|
Evolution, Molecular | 1 | 2000 | 1939 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 2020 | 4185 | 0.020 |
Why?
|
Methotrexate | 6 | 1990 | 1728 | 0.020 |
Why?
|
Cell Adhesion Molecules | 1 | 1997 | 1602 | 0.020 |
Why?
|
HIV Infections | 1 | 1997 | 16715 | 0.020 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2019 | 1524 | 0.020 |
Why?
|
Chromosomes, Human, Pair 14 | 2 | 2006 | 299 | 0.020 |
Why?
|
Leukemia, Lymphoid | 2 | 1981 | 315 | 0.020 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2019 | 3480 | 0.020 |
Why?
|
Neoplasms, Multiple Primary | 2 | 2006 | 604 | 0.020 |
Why?
|
Mikulicz' Disease | 1 | 1970 | 8 | 0.020 |
Why?
|
Blotting, Southern | 1 | 1991 | 803 | 0.020 |
Why?
|
Capillaries | 1 | 2013 | 773 | 0.020 |
Why?
|
Gene Amplification | 1 | 2014 | 1063 | 0.020 |
Why?
|
Ki-67 Antigen | 1 | 2012 | 644 | 0.020 |
Why?
|
Genetic Association Studies | 1 | 2019 | 2703 | 0.020 |
Why?
|
Gene Dosage | 1 | 2014 | 1252 | 0.020 |
Why?
|
Epstein-Barr Virus Infections | 2 | 2009 | 570 | 0.020 |
Why?
|
Perforin | 1 | 2010 | 168 | 0.020 |
Why?
|
beta Catenin | 1 | 2015 | 1059 | 0.020 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2008 | 5223 | 0.020 |
Why?
|
Combined Modality Therapy | 2 | 2019 | 8642 | 0.020 |
Why?
|
Blood Vessels | 2 | 2005 | 1125 | 0.020 |
Why?
|
Sezary Syndrome | 2 | 1981 | 76 | 0.020 |
Why?
|
Observer Variation | 1 | 2016 | 2593 | 0.020 |
Why?
|
Jurkat Cells | 1 | 2011 | 743 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-akt | 2 | 2010 | 2504 | 0.020 |
Why?
|
Tumor Cells, Cultured | 4 | 2001 | 6313 | 0.020 |
Why?
|
Genes, Tumor Suppressor | 1 | 2014 | 1097 | 0.020 |
Why?
|
Penicillinase | 1 | 1968 | 9 | 0.020 |
Why?
|
Epithelial Cells | 3 | 2007 | 3690 | 0.020 |
Why?
|
Toe Joint | 1 | 1988 | 19 | 0.020 |
Why?
|
Radiography, Interventional | 1 | 1996 | 1095 | 0.020 |
Why?
|
Elbow | 1 | 2009 | 138 | 0.020 |
Why?
|
Penicillin Resistance | 1 | 1968 | 84 | 0.020 |
Why?
|
Sequence Homology, Nucleic Acid | 2 | 2000 | 1085 | 0.020 |
Why?
|
RNA | 1 | 2019 | 2749 | 0.020 |
Why?
|
Multiprotein Complexes | 1 | 2015 | 1120 | 0.020 |
Why?
|
DNA, Neoplasm | 3 | 2003 | 1758 | 0.020 |
Why?
|
RNA, Small Interfering | 1 | 2018 | 3505 | 0.020 |
Why?
|
Menstruation | 2 | 2006 | 302 | 0.020 |
Why?
|
Artificial Intelligence | 1 | 2002 | 2213 | 0.020 |
Why?
|
Single-Cell Analysis | 1 | 2019 | 2182 | 0.020 |
Why?
|
Amniotic Fluid | 1 | 1970 | 370 | 0.020 |
Why?
|
Groin | 1 | 1988 | 105 | 0.020 |
Why?
|
Germinoma | 1 | 2009 | 134 | 0.020 |
Why?
|
Aortitis | 1 | 1989 | 74 | 0.020 |
Why?
|
Amino Acid Sequence | 3 | 2000 | 13814 | 0.020 |
Why?
|
Abdominal Neoplasms | 1 | 1990 | 292 | 0.020 |
Why?
|
Bacteroides | 1 | 1968 | 161 | 0.020 |
Why?
|
Diaphragm | 1 | 1990 | 349 | 0.020 |
Why?
|
Bone Marrow Transplantation | 2 | 1993 | 2765 | 0.020 |
Why?
|
Fibroblast Growth Factors | 1 | 1994 | 878 | 0.020 |
Why?
|
Tumor Burden | 1 | 2014 | 1915 | 0.020 |
Why?
|
Ependyma | 1 | 2007 | 54 | 0.020 |
Why?
|
Phosphorylation | 2 | 2010 | 8436 | 0.020 |
Why?
|
Immunoglobulin Variable Region | 1 | 2009 | 421 | 0.020 |
Why?
|
Testosterone | 2 | 1975 | 2419 | 0.020 |
Why?
|
Leucovorin | 5 | 1990 | 628 | 0.020 |
Why?
|
Dromaiidae | 1 | 2007 | 7 | 0.020 |
Why?
|
Mice, Inbred C57BL | 2 | 2021 | 21833 | 0.020 |
Why?
|
United States | 2 | 2014 | 69872 | 0.020 |
Why?
|
Evaluation Studies as Topic | 1 | 1990 | 1681 | 0.020 |
Why?
|
Histiocytic Sarcoma | 1 | 2007 | 44 | 0.020 |
Why?
|
Carcinoma, Renal Cell | 1 | 2002 | 3143 | 0.020 |
Why?
|
Immunoglobulin G | 4 | 1997 | 4561 | 0.020 |
Why?
|
Hypergammaglobulinemia | 1 | 2007 | 74 | 0.020 |
Why?
|
Phycoerythrin | 1 | 1986 | 8 | 0.020 |
Why?
|
Forearm | 1 | 2009 | 409 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2015 | 3554 | 0.020 |
Why?
|
Nephritis, Interstitial | 1 | 1988 | 154 | 0.020 |
Why?
|
Deoxyribonucleases | 1 | 1988 | 214 | 0.020 |
Why?
|
Cytogenetics | 2 | 2000 | 203 | 0.020 |
Why?
|
Chemical Precipitation | 3 | 1971 | 179 | 0.020 |
Why?
|
Electrophoretic Mobility Shift Assay | 1 | 2007 | 300 | 0.020 |
Why?
|
Tolonium Chloride | 1 | 1986 | 23 | 0.020 |
Why?
|
Androstane-3,17-diol | 1 | 1986 | 19 | 0.020 |
Why?
|
Colonic Neoplasms | 3 | 1974 | 2542 | 0.020 |
Why?
|
Lymphocyte Culture Test, Mixed | 2 | 1997 | 518 | 0.020 |
Why?
|
Erythema | 1 | 2008 | 257 | 0.020 |
Why?
|
Adenoma, Islet Cell | 2 | 1983 | 82 | 0.020 |
Why?
|
Repressor Proteins | 1 | 2017 | 3024 | 0.020 |
Why?
|
ROC Curve | 1 | 2014 | 3528 | 0.020 |
Why?
|
Calmodulin-Binding Proteins | 1 | 2007 | 250 | 0.020 |
Why?
|
Splenic Neoplasms | 2 | 1985 | 100 | 0.020 |
Why?
|
Intestinal Mucosa | 3 | 2005 | 3037 | 0.020 |
Why?
|
Patient Selection | 1 | 2018 | 4216 | 0.020 |
Why?
|
Estradiol | 3 | 1986 | 2020 | 0.020 |
Why?
|
Quaternary Ammonium Compounds | 3 | 1971 | 205 | 0.020 |
Why?
|
Prospective Studies | 3 | 2020 | 53290 | 0.020 |
Why?
|
Inhibitor of Apoptosis Proteins | 1 | 2006 | 215 | 0.020 |
Why?
|
Endocrine Glands | 1 | 2006 | 103 | 0.020 |
Why?
|
Neoplasm Invasiveness | 1 | 2014 | 3616 | 0.020 |
Why?
|
Binding Sites | 2 | 1988 | 6111 | 0.020 |
Why?
|
Dexamethasone | 6 | 1990 | 1951 | 0.020 |
Why?
|
Open Reading Frames | 2 | 2000 | 811 | 0.020 |
Why?
|
Radioimmunoassay | 1 | 1986 | 919 | 0.020 |
Why?
|
Pregnancy | 4 | 1997 | 29144 | 0.020 |
Why?
|
Hematopoietic Stem Cells | 1 | 2018 | 3390 | 0.020 |
Why?
|
Androstenedione | 2 | 1975 | 131 | 0.020 |
Why?
|
Microscopy, Immunoelectron | 1 | 2005 | 319 | 0.020 |
Why?
|
Bone Transplantation | 2 | 1997 | 907 | 0.020 |
Why?
|
Fetal Diseases | 1 | 1970 | 903 | 0.020 |
Why?
|
Cloning, Molecular | 2 | 2001 | 4320 | 0.020 |
Why?
|
Neoplasm Recurrence, Local | 4 | 2012 | 9240 | 0.020 |
Why?
|
Up-Regulation | 2 | 2009 | 4222 | 0.020 |
Why?
|
Area Under Curve | 1 | 2009 | 1655 | 0.020 |
Why?
|
HLA-DR Antigens | 1 | 1986 | 645 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2014 | 4208 | 0.020 |
Why?
|
Antigens, CD1 | 1 | 2007 | 437 | 0.020 |
Why?
|
Thyroid Gland | 1 | 1991 | 1173 | 0.020 |
Why?
|
Endoderm | 1 | 2005 | 154 | 0.020 |
Why?
|
Respiratory System | 1 | 2007 | 557 | 0.020 |
Why?
|
Somatostatinoma | 1 | 1983 | 10 | 0.020 |
Why?
|
Viral Proteins | 2 | 1999 | 1900 | 0.010 |
Why?
|
GPI-Linked Proteins | 1 | 2005 | 435 | 0.010 |
Why?
|
Sarcoma, Synovial | 1 | 1985 | 167 | 0.010 |
Why?
|
RNA, Messenger | 3 | 2005 | 13035 | 0.010 |
Why?
|
Data Interpretation, Statistical | 1 | 1994 | 2716 | 0.010 |
Why?
|
Perineum | 1 | 1985 | 211 | 0.010 |
Why?
|
Tetracyclines | 1 | 2004 | 60 | 0.010 |
Why?
|
Running | 1 | 1988 | 480 | 0.010 |
Why?
|
Orchiectomy | 1 | 1986 | 474 | 0.010 |
Why?
|
Carbon Radioisotopes | 2 | 1975 | 577 | 0.010 |
Why?
|
Goiter, Substernal | 1 | 1983 | 17 | 0.010 |
Why?
|
Eosinophils | 2 | 1999 | 955 | 0.010 |
Why?
|
Intestinal Absorption | 1 | 2005 | 420 | 0.010 |
Why?
|
Treatment Failure | 1 | 2009 | 2618 | 0.010 |
Why?
|
17-Hydroxycorticosteroids | 2 | 1974 | 40 | 0.010 |
Why?
|
Mucins | 1 | 1987 | 564 | 0.010 |
Why?
|
Immunoglobulin A | 2 | 1997 | 995 | 0.010 |
Why?
|
Medulloblastoma | 1 | 2009 | 683 | 0.010 |
Why?
|
Cytoplasmic Granules | 1 | 1986 | 610 | 0.010 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2006 | 625 | 0.010 |
Why?
|
Antigens, CD20 | 2 | 1995 | 199 | 0.010 |
Why?
|
Pigmentation Disorders | 1 | 2004 | 101 | 0.010 |
Why?
|
Common Bile Duct Neoplasms | 1 | 1983 | 111 | 0.010 |
Why?
|
Chemokine CCL22 | 1 | 2002 | 26 | 0.010 |
Why?
|
Chemokine CCL17 | 1 | 2002 | 23 | 0.010 |
Why?
|
Macrophage Inflammatory Proteins | 1 | 2003 | 123 | 0.010 |
Why?
|
Methylation | 1 | 2006 | 1106 | 0.010 |
Why?
|
Ampulla of Vater | 1 | 1983 | 141 | 0.010 |
Why?
|
Bone Diseases | 1 | 2007 | 416 | 0.010 |
Why?
|
Rheumatoid Nodule | 2 | 1989 | 15 | 0.010 |
Why?
|
Chemokine CCL20 | 1 | 2003 | 65 | 0.010 |
Why?
|
Carcinoma, Small Cell | 1 | 1985 | 420 | 0.010 |
Why?
|
Purpura | 1 | 2004 | 122 | 0.010 |
Why?
|
Salivary Glands | 2 | 1983 | 229 | 0.010 |
Why?
|
Receptors, CCR7 | 1 | 2003 | 108 | 0.010 |
Why?
|
Massachusetts | 1 | 2016 | 8662 | 0.010 |
Why?
|
Receptors, CCR6 | 1 | 2003 | 81 | 0.010 |
Why?
|
Wound Healing | 1 | 1994 | 2785 | 0.010 |
Why?
|
DNA, Viral | 2 | 2000 | 2227 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 3 | 2019 | 35425 | 0.010 |
Why?
|
Receptors, CCR4 | 1 | 2002 | 81 | 0.010 |
Why?
|
Fibrocystic Breast Disease | 1 | 1983 | 102 | 0.010 |
Why?
|
Organ Specificity | 1 | 2007 | 2008 | 0.010 |
Why?
|
Mice, Knockout | 2 | 2010 | 14561 | 0.010 |
Why?
|
Neutrophils | 2 | 2010 | 3721 | 0.010 |
Why?
|
Proinsulin | 2 | 1979 | 133 | 0.010 |
Why?
|
Oxidative Phosphorylation | 1 | 2004 | 481 | 0.010 |
Why?
|
Receptors, Cell Surface | 1 | 2012 | 2865 | 0.010 |
Why?
|
Neuromuscular Diseases | 1 | 2005 | 247 | 0.010 |
Why?
|
Metaplasia | 1 | 1983 | 313 | 0.010 |
Why?
|
Anal Canal | 1 | 1985 | 376 | 0.010 |
Why?
|
Gold | 1 | 1986 | 484 | 0.010 |
Why?
|
Reactive Oxygen Species | 1 | 2010 | 2076 | 0.010 |
Why?
|
RNA Splicing | 1 | 2007 | 908 | 0.010 |
Why?
|
STAT1 Transcription Factor | 1 | 2003 | 320 | 0.010 |
Why?
|
Colonic Diseases | 2 | 1974 | 202 | 0.010 |
Why?
|
Silicone Gels | 1 | 2002 | 39 | 0.010 |
Why?
|
Carcinoid Tumor | 1 | 1983 | 235 | 0.010 |
Why?
|
Dermatitis | 1 | 2004 | 199 | 0.010 |
Why?
|
Active Transport, Cell Nucleus | 1 | 2003 | 443 | 0.010 |
Why?
|
Mucoproteins | 1 | 1981 | 50 | 0.010 |
Why?
|
Salivary Gland Neoplasms | 1 | 1985 | 298 | 0.010 |
Why?
|
Muscle Fibers, Skeletal | 1 | 2005 | 555 | 0.010 |
Why?
|
Immunoglobulin Fab Fragments | 1 | 1983 | 482 | 0.010 |
Why?
|
Pneumonia | 1 | 2013 | 2133 | 0.010 |
Why?
|
Age of Onset | 1 | 2008 | 3270 | 0.010 |
Why?
|
Cattle | 2 | 1985 | 3922 | 0.010 |
Why?
|
Autoantigens | 1 | 2005 | 892 | 0.010 |
Why?
|
Interleukin-13 | 1 | 2003 | 389 | 0.010 |
Why?
|
Genes, bcl-2 | 1 | 2001 | 122 | 0.010 |
Why?
|
Genes, cdc | 1 | 2001 | 116 | 0.010 |
Why?
|
Infant, Newborn | 2 | 2012 | 25628 | 0.010 |
Why?
|
Receptors, Complement | 1 | 1981 | 264 | 0.010 |
Why?
|
Lymphatic Metastasis | 3 | 1985 | 2924 | 0.010 |
Why?
|
Estriol | 2 | 1970 | 53 | 0.010 |
Why?
|
Dogs | 1 | 1986 | 3912 | 0.010 |
Why?
|
Centrifugation | 2 | 1971 | 122 | 0.010 |
Why?
|
Fluorometry | 2 | 1970 | 106 | 0.010 |
Why?
|
Lymphoma, AIDS-Related | 1 | 2001 | 84 | 0.010 |
Why?
|
Gene Expression Regulation | 2 | 2012 | 12073 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-bcl-6 | 1 | 2001 | 193 | 0.010 |
Why?
|
Chromosome Walking | 1 | 2000 | 27 | 0.010 |
Why?
|
Thiamine | 1 | 2001 | 152 | 0.010 |
Why?
|
Transcriptional Activation | 1 | 2007 | 1783 | 0.010 |
Why?
|
Subcellular Fractions | 1 | 1981 | 547 | 0.010 |
Why?
|
Colorimetry | 2 | 1971 | 147 | 0.010 |
Why?
|
Contig Mapping | 1 | 1999 | 54 | 0.010 |
Why?
|
Chromosomes, Artificial, Yeast | 1 | 1999 | 118 | 0.010 |
Why?
|
Yolk Sac | 1 | 2000 | 75 | 0.010 |
Why?
|
Factor VIII | 1 | 1982 | 347 | 0.010 |
Why?
|
Chemotaxis | 1 | 2003 | 607 | 0.010 |
Why?
|
Antineoplastic Agents, Phytogenic | 1 | 2004 | 624 | 0.010 |
Why?
|
Desmosomes | 1 | 1979 | 73 | 0.010 |
Why?
|
Pregnancy Complications | 2 | 1970 | 2861 | 0.010 |
Why?
|
Sulfates | 2 | 1971 | 390 | 0.010 |
Why?
|
Cell Line, Transformed | 1 | 2001 | 898 | 0.010 |
Why?
|
Breast Diseases | 1 | 1983 | 443 | 0.010 |
Why?
|
Cell Transformation, Viral | 1 | 2001 | 567 | 0.010 |
Why?
|
Gene Rearrangement, gamma-Chain T-Cell Antigen Receptor | 1 | 1999 | 43 | 0.010 |
Why?
|
Nasopharyngeal Neoplasms | 1 | 1982 | 286 | 0.010 |
Why?
|
Molecular Weight | 1 | 1981 | 2255 | 0.010 |
Why?
|
Carboxypeptidases | 1 | 1979 | 176 | 0.010 |
Why?
|
Ultrasonography | 1 | 1992 | 5984 | 0.010 |
Why?
|
Genome, Human | 1 | 2012 | 4420 | 0.010 |
Why?
|
Cyclin D | 1 | 1999 | 72 | 0.010 |
Why?
|
Actuarial Analysis | 2 | 1993 | 378 | 0.010 |
Why?
|
Disease-Free Survival | 1 | 2009 | 6896 | 0.010 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2014 | 5172 | 0.010 |
Why?
|
Keratinocytes | 1 | 2003 | 799 | 0.010 |
Why?
|
Embryo, Mammalian | 1 | 2005 | 1701 | 0.010 |
Why?
|
Diverticulitis, Colonic | 3 | 1974 | 128 | 0.010 |
Why?
|
Cervix Uteri | 1 | 1982 | 590 | 0.010 |
Why?
|
Complement System Proteins | 2 | 1979 | 795 | 0.010 |
Why?
|
Mice, Inbred Strains | 1 | 2001 | 1828 | 0.010 |
Why?
|
Pneumothorax | 1 | 1982 | 379 | 0.010 |
Why?
|
Communicable Diseases | 1 | 2007 | 880 | 0.010 |
Why?
|
Cardiac Tamponade | 1 | 1979 | 173 | 0.010 |
Why?
|
Immunity | 1 | 2004 | 1014 | 0.010 |
Why?
|
Teratoma | 1 | 1981 | 395 | 0.010 |
Why?
|
Pericarditis | 1 | 1979 | 128 | 0.010 |
Why?
|
Receptors, Fc | 1 | 1981 | 541 | 0.010 |
Why?
|
Esterases | 1 | 1977 | 95 | 0.010 |
Why?
|
Arthritis, Rheumatoid | 2 | 1995 | 3712 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2019 | 17446 | 0.010 |
Why?
|
Xenopus | 1 | 2000 | 712 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2008 | 6539 | 0.010 |
Why?
|
Papillomaviridae | 1 | 1984 | 1119 | 0.010 |
Why?
|
Shoulder | 1 | 1979 | 299 | 0.010 |
Why?
|
Cluster Analysis | 1 | 2004 | 2715 | 0.010 |
Why?
|
RNA, Neoplasm | 1 | 2000 | 769 | 0.010 |
Why?
|
Vagina | 1 | 1982 | 825 | 0.010 |
Why?
|
Confusion | 1 | 1999 | 275 | 0.010 |
Why?
|
Osteoblasts | 1 | 2003 | 1166 | 0.010 |
Why?
|
Swine | 2 | 1985 | 5918 | 0.010 |
Why?
|
Antibodies, Heterophile | 1 | 1997 | 126 | 0.010 |
Why?
|
Transplantation, Homologous | 3 | 1993 | 4777 | 0.010 |
Why?
|
Fetal Tissue Transplantation | 1 | 1997 | 139 | 0.010 |
Why?
|
Oncogene Proteins, Viral | 1 | 1998 | 362 | 0.010 |
Why?
|
Introns | 1 | 1999 | 992 | 0.010 |
Why?
|
Erythropoiesis | 1 | 1981 | 706 | 0.010 |
Why?
|
DNA, Complementary | 1 | 2000 | 2050 | 0.010 |
Why?
|
Cyclins | 1 | 1999 | 603 | 0.010 |
Why?
|
Protein Isoforms | 1 | 2001 | 1730 | 0.010 |
Why?
|
Embryo, Nonmammalian | 1 | 2000 | 895 | 0.010 |
Why?
|
Caspases | 1 | 1999 | 928 | 0.010 |
Why?
|
Pilot Projects | 1 | 2009 | 8319 | 0.010 |
Why?
|
Paclitaxel | 1 | 2004 | 1708 | 0.010 |
Why?
|
Muscles | 1 | 1981 | 1614 | 0.010 |
Why?
|
Immunoglobulin Light Chains | 1 | 1977 | 277 | 0.010 |
Why?
|
Virus Latency | 1 | 1998 | 358 | 0.010 |
Why?
|
Intestines | 1 | 2005 | 1924 | 0.010 |
Why?
|
Acute Disease | 1 | 2006 | 7147 | 0.010 |
Why?
|
Kidney Diseases | 1 | 2007 | 2148 | 0.010 |
Why?
|
Hydrogen-Ion Concentration | 2 | 1971 | 2556 | 0.010 |
Why?
|
Fluorescein-5-isothiocyanate | 1 | 1996 | 225 | 0.010 |
Why?
|
Salvage Therapy | 2 | 1993 | 1275 | 0.010 |
Why?
|
Time Factors | 6 | 1998 | 40075 | 0.010 |
Why?
|
Acute Kidney Injury | 1 | 1988 | 1968 | 0.010 |
Why?
|
Alkaline Phosphatase | 1 | 1979 | 867 | 0.010 |
Why?
|
Adenoma | 2 | 1983 | 2174 | 0.010 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2000 | 2839 | 0.010 |
Why?
|
Antigen-Antibody Reactions | 1 | 1995 | 363 | 0.010 |
Why?
|
Chromatography, Paper | 1 | 1974 | 77 | 0.010 |
Why?
|
Leydig Cells | 1 | 1974 | 56 | 0.010 |
Why?
|
Gastric Mucosa | 1 | 1998 | 599 | 0.010 |
Why?
|
Dihydrotestosterone | 1 | 1975 | 190 | 0.010 |
Why?
|
Organoids | 1 | 1980 | 701 | 0.010 |
Why?
|
Cecum | 1 | 1975 | 237 | 0.010 |
Why?
|
Thymus Gland | 1 | 1979 | 1267 | 0.010 |
Why?
|
Immunoglobulin lambda-Chains | 2 | 1984 | 87 | 0.010 |
Why?
|
Uterine Neoplasms | 1 | 1984 | 1513 | 0.010 |
Why?
|
Sclerosis | 1 | 1994 | 213 | 0.010 |
Why?
|
Gonadotropins | 1 | 1974 | 241 | 0.010 |
Why?
|
Lip | 1 | 1975 | 195 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2005 | 5867 | 0.010 |
Why?
|
Trans-Activators | 1 | 2003 | 2926 | 0.010 |
Why?
|
Rectal Diseases | 1 | 1974 | 143 | 0.010 |
Why?
|
Chromosome Mapping | 1 | 2001 | 4740 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2007 | 7721 | 0.010 |
Why?
|
Confidence Intervals | 1 | 1998 | 2971 | 0.010 |
Why?
|
Intestinal Perforation | 1 | 1974 | 253 | 0.010 |
Why?
|
Canada | 2 | 1976 | 2065 | 0.010 |
Why?
|
Fiber Optic Technology | 1 | 1974 | 290 | 0.010 |
Why?
|
Lymphopenia | 1 | 1995 | 285 | 0.010 |
Why?
|
RNA-Binding Proteins | 1 | 2001 | 1903 | 0.010 |
Why?
|
Inflammation | 2 | 2007 | 10637 | 0.010 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2000 | 1581 | 0.010 |
Why?
|
Antigens, CD19 | 1 | 1995 | 380 | 0.010 |
Why?
|
Fishes | 1 | 1975 | 569 | 0.010 |
Why?
|
Nerve Tissue Proteins | 1 | 2005 | 4463 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 1989 | 8949 | 0.010 |
Why?
|
Thyroid Neoplasms | 1 | 1985 | 2282 | 0.010 |
Why?
|
Uterine Cervical Neoplasms | 1 | 1984 | 2020 | 0.010 |
Why?
|
Hematopoiesis | 1 | 1981 | 2073 | 0.010 |
Why?
|
Sulfuric Acids | 1 | 1971 | 37 | 0.010 |
Why?
|
Knee Prosthesis | 1 | 1995 | 425 | 0.010 |
Why?
|
Goiter | 1 | 1991 | 87 | 0.010 |
Why?
|
Chromosomes, Human, Pair 12 | 1 | 1992 | 462 | 0.010 |
Why?
|
Anencephaly | 1 | 1970 | 20 | 0.010 |
Why?
|
Metaphase | 1 | 1991 | 151 | 0.010 |
Why?
|
Drug Therapy, Combination | 3 | 1976 | 6489 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2008 | 21748 | 0.010 |
Why?
|
Placenta | 1 | 2000 | 1699 | 0.010 |
Why?
|
Mammography | 1 | 2002 | 2475 | 0.010 |
Why?
|
Vimentin | 1 | 1991 | 262 | 0.010 |
Why?
|
Erythroblastosis, Fetal | 1 | 1970 | 60 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 3 | 1990 | 10943 | 0.010 |
Why?
|
RNA, Viral | 1 | 1998 | 2901 | 0.010 |
Why?
|
Trisomy | 1 | 1991 | 266 | 0.010 |
Why?
|
Dehydroepiandrosterone | 1 | 1971 | 252 | 0.010 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2001 | 3617 | 0.010 |
Why?
|
Splenomegaly | 1 | 1990 | 190 | 0.010 |
Why?
|
Uterine Cervical Dysplasia | 2 | 1984 | 387 | 0.010 |
Why?
|
Lymphography | 1 | 1990 | 201 | 0.010 |
Why?
|
Pregnancy in Diabetics | 1 | 1970 | 179 | 0.010 |
Why?
|
Oxacillin | 1 | 1968 | 42 | 0.010 |
Why?
|
Transplantation, Heterologous | 1 | 1997 | 2383 | 0.010 |
Why?
|
Cytological Techniques | 1 | 1991 | 219 | 0.010 |
Why?
|
Penicillin G | 1 | 1968 | 42 | 0.010 |
Why?
|
Intestine, Small | 1 | 1975 | 1240 | 0.010 |
Why?
|
Chromatography, Thin Layer | 1 | 1968 | 223 | 0.010 |
Why?
|
Ampicillin | 1 | 1968 | 139 | 0.010 |
Why?
|
Cell Adhesion | 1 | 1995 | 3144 | 0.010 |
Why?
|
Drug Administration Schedule | 2 | 1987 | 4933 | 0.010 |
Why?
|
Zebrafish | 1 | 2000 | 2996 | 0.010 |
Why?
|
Transplantation, Autologous | 1 | 1993 | 2124 | 0.000 |
Why?
|
Autoimmune Diseases | 1 | 2000 | 2134 | 0.000 |
Why?
|
Cytomegalovirus Infections | 1 | 1974 | 820 | 0.000 |
Why?
|
Aging | 1 | 2007 | 8664 | 0.000 |
Why?
|
Laparotomy | 1 | 1990 | 473 | 0.000 |
Why?
|
Radiotherapy Dosage | 1 | 1993 | 2879 | 0.000 |
Why?
|
Colon | 1 | 1974 | 1772 | 0.000 |
Why?
|
Risk Factors | 2 | 2006 | 72296 | 0.000 |
Why?
|
Administration, Oral | 1 | 1994 | 3914 | 0.000 |
Why?
|
Odds Ratio | 1 | 1998 | 9849 | 0.000 |
Why?
|
Aorta, Abdominal | 1 | 1989 | 646 | 0.000 |
Why?
|
Shoulder Joint | 1 | 1992 | 695 | 0.000 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 1997 | 4424 | 0.000 |
Why?
|
Central Nervous System Diseases | 1 | 1990 | 518 | 0.000 |
Why?
|
Exocrine Glands | 1 | 1985 | 50 | 0.000 |
Why?
|
Socioeconomic Factors | 1 | 1998 | 7785 | 0.000 |
Why?
|
Hot Temperature | 1 | 1970 | 1356 | 0.000 |
Why?
|
Endoscopy | 1 | 1974 | 1787 | 0.000 |
Why?
|
Probability | 1 | 1990 | 2506 | 0.000 |
Why?
|
Postoperative Complications | 2 | 1999 | 15297 | 0.000 |
Why?
|
Recombinant Proteins | 1 | 1994 | 6621 | 0.000 |
Why?
|
Myometrium | 1 | 1985 | 181 | 0.000 |
Why?
|
Thyroid Nodule | 1 | 1991 | 750 | 0.000 |
Why?
|
Viral Structural Proteins | 1 | 1984 | 103 | 0.000 |
Why?
|
Risk | 1 | 1976 | 9688 | 0.000 |
Why?
|
Rats, Sprague-Dawley | 1 | 1994 | 8300 | 0.000 |
Why?
|
Aorta, Thoracic | 1 | 1989 | 1084 | 0.000 |
Why?
|
Gynecomastia | 1 | 1983 | 88 | 0.000 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 1995 | 4386 | 0.000 |
Why?
|
Uromodulin | 1 | 1981 | 46 | 0.000 |
Why?
|
Age Factors | 2 | 1990 | 18373 | 0.000 |
Why?
|
Urinary Tract | 1 | 1985 | 309 | 0.000 |
Why?
|
Axilla | 1 | 1984 | 597 | 0.000 |
Why?
|
Vulvar Neoplasms | 1 | 1984 | 272 | 0.000 |
Why?
|
Tomography, X-Ray Computed | 3 | 1991 | 20130 | 0.000 |
Why?
|
Lacrimal Apparatus | 1 | 1983 | 225 | 0.000 |
Why?
|
Tumor Virus Infections | 1 | 1984 | 454 | 0.000 |
Why?
|
Immunodiffusion | 1 | 1979 | 163 | 0.000 |
Why?
|
Carcinoma, Papillary | 1 | 1985 | 783 | 0.000 |
Why?
|
Leukocyte Count | 1 | 1983 | 1588 | 0.000 |
Why?
|
Thyroidectomy | 1 | 1985 | 879 | 0.000 |
Why?
|
Prostatic Neoplasms | 1 | 1982 | 11126 | 0.000 |
Why?
|
Muscle, Smooth, Vascular | 1 | 1985 | 1504 | 0.000 |
Why?
|
Glucose | 1 | 1970 | 4398 | 0.000 |
Why?
|
Clinical Trials as Topic | 2 | 1990 | 7914 | 0.000 |
Why?
|
Carcinoma in Situ | 1 | 1984 | 806 | 0.000 |
Why?
|
Rats | 1 | 1994 | 24252 | 0.000 |
Why?
|
Pain | 1 | 1992 | 4988 | 0.000 |
Why?
|
Diet | 1 | 1975 | 7937 | 0.000 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 1979 | 1801 | 0.000 |
Why?
|
Immune Adherence Reaction | 1 | 1976 | 32 | 0.000 |
Why?
|
Regression Analysis | 1 | 1986 | 6459 | 0.000 |
Why?
|
Breast | 1 | 1985 | 1970 | 0.000 |
Why?
|
Binding Sites, Antibody | 1 | 1975 | 349 | 0.000 |
Why?
|
Species Specificity | 1 | 1979 | 2478 | 0.000 |
Why?
|
Parotid Gland | 1 | 1975 | 168 | 0.000 |
Why?
|
Nitrogen Mustard Compounds | 1 | 1974 | 45 | 0.000 |
Why?
|
Procarbazine | 1 | 1974 | 181 | 0.000 |
Why?
|
Remission, Spontaneous | 1 | 1974 | 382 | 0.000 |
Why?
|
Meningeal Neoplasms | 1 | 1983 | 1241 | 0.000 |
Why?
|
Drug Evaluation | 1 | 1974 | 647 | 0.000 |
Why?
|
Sheep | 1 | 1975 | 1437 | 0.000 |
Why?
|
Antibodies | 1 | 1979 | 2460 | 0.000 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 1974 | 1131 | 0.000 |
Why?
|
Peptide Fragments | 1 | 1979 | 5096 | 0.000 |
Why?
|
Drug Resistance, Microbial | 1 | 1969 | 862 | 0.000 |
Why?
|
Colitis | 1 | 1974 | 1170 | 0.000 |
Why?
|
Radiography | 1 | 1976 | 7023 | 0.000 |
Why?
|
Rectal Neoplasms | 1 | 1974 | 1205 | 0.000 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 1979 | 3338 | 0.000 |
Why?
|
Insulin | 1 | 1979 | 6582 | 0.000 |
Why?
|
Colitis, Ulcerative | 1 | 1974 | 1911 | 0.000 |
Why?
|
Palliative Care | 1 | 1974 | 3493 | 0.000 |
Why?
|